Laduviglusib (CHIR-99021) (GMP) is Laduviglusib (HY-10182) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Laduviglusib is a potent, orally active and selective GSK-3alpha/beta inhibitor.
Molecular Weight:
465.34
CAS Number:
[252917-06-9]
Formula:
C22H18Cl2N8
Target:
Autophagy,GSK-3,Wnt,beta-catenin
Application Notes:
MCE Product type: GMP Small Molecules
* VAT and and shipping costs not included. Errors and price changes excepted
